rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2001-5-29
|
pubmed:abstractText |
Metoprolol is a beta(1)-selective beta-adrenergic antagonist while carvedilol is a non-selective beta-blocker with additional blockades of alpha(1)-adrenoceptors. Administration of metoprolol has been shown to cause up-regulation of beta-adrenoceptor density and to decrease nocturnal melatonin release, whereas carvedilol lacks these typical effects of beta-blocking drugs.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1388-9842
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
343-9
|
pubmed:dateRevised |
2011-6-8
|
pubmed:meshHeading |
pubmed-meshheading:11378006-Administration, Oral,
pubmed-meshheading:11378006-Adrenergic beta-Antagonists,
pubmed-meshheading:11378006-Adult,
pubmed-meshheading:11378006-Blood Pressure,
pubmed-meshheading:11378006-Carbazoles,
pubmed-meshheading:11378006-Cross-Over Studies,
pubmed-meshheading:11378006-Double-Blind Method,
pubmed-meshheading:11378006-Exercise Test,
pubmed-meshheading:11378006-Heart Failure,
pubmed-meshheading:11378006-Heart Rate,
pubmed-meshheading:11378006-Humans,
pubmed-meshheading:11378006-Male,
pubmed-meshheading:11378006-Metoprolol,
pubmed-meshheading:11378006-Middle Aged,
pubmed-meshheading:11378006-Propanolamines,
pubmed-meshheading:11378006-Reference Values
|
pubmed:year |
2001
|
pubmed:articleTitle |
Differing beta-blocking effects of carvedilol and metoprolol.
|
pubmed:affiliation |
Medizinische Universitätsklinik, Abteilung für Kardiologie, Graz, Austria. kurt.stoschitzky@kfunigraz.ac.at
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|